BioNTech SE (BNTX)

BioNTech SE (BNTX) Financial Statements


BioNTech SE Financial Overview

BioNTech SE's market cap is currently ―. The company's EPS TTM is $46.733; its P/E ratio is 3.07; BioNTech SE is scheduled to report earnings on March 29, 2023, and the estimated EPS forecast is $8.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue€ 3.46B€ 3.20B€ 6.37B€ 5.53B€ 6.09B
Gross Profit€ 2.37B€ 2.03B€ 4.79B€ 4.68B€ 4.62B
EBIT€ 2.45B€ 2.33B€ 5.02B€ 4.72B€ 4.67B
EBITDA€ 2.48B€ 2.36B€ 5.05B€ 4.74B€ 4.69B
Net Income Common Stockholders€ 1.78B€ 1.67B€ 3.70B€ 3.17B€ 3.21B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 13.43B€ 9.33B€ 6.17B€ 2.07B€ 2.39B
Total Assets€ 22.66B€ 21.16B€ 20.30B€ 15.83B€ 14.23B
Total Debt€ 274.00M€ 238.90M€ 186.00M€ 301.50M€ 286.70M
Net Debt€ -13.15B€ -9.10B€ -5.98B€ -1.77B€ -2.11B
Total Liabilities€ 4.29B€ 4.32B€ 4.39B€ 3.94B€ 5.52B
Stockholders Equity€ 18.37B€ 16.83B€ 15.91B€ 11.89B€ 8.71B
Cash Flow-
Free Cash Flow€ 4.70B€ 3.84B€ 3.99B€ -252.90M€ 1.46B
Operating Cash Flow€ 4.78B€ 3.92B€ 4.05B€ -199.50M€ 1.50B
Investing Cash Flow€ -83.30M€ -78.40M€ 287.40M€ -466.90M€ -41.10M
Financing Cash Flow€ -653.40M€ -781.50M€ 80.30M€ -48.90M€ -5.30M
Currency in EUR

BioNTech SE Earnings and Revenue History

BioNTech SE Debt to Assets

BioNTech SE Cash Flow

BioNTech SE Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis